BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 15452407)

  • 1. Penciclovir cream--improved topical treatment for herpes simplex infections.
    Schmid-Wendtner MH; Korting HC
    Skin Pharmacol Physiol; 2004; 17(5):214-8. PubMed ID: 15452407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
    Lin L; Chen XS; Cui PG; Wang JB; Guo ZP; Lu NZ; Bi ZG; Jia H; Yang XY;
    J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
    Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R
    Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
    Tyring SK; Baker D; Snowden W
    J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel agents and strategies to treat herpes simplex virus infections.
    Kleymann G
    Expert Opin Investig Drugs; 2003 Feb; 12(2):165-83. PubMed ID: 12556212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
    Spruance SL; Rea TL; Thoming C; Tucker R; Saltzman R; Boon R
    JAMA; 1997 May; 277(17):1374-9. PubMed ID: 9134943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection.
    McKeough MB; Spruance SL
    Arch Dermatol; 2001 Sep; 137(9):1153-8. PubMed ID: 11559210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical acyclovir in the treatment of recurrent herpes simplex virus infections.
    Kinghorn GR
    Scand J Infect Dis Suppl; 1985; 47():58-62. PubMed ID: 3912972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Herpes simplex virus infections with topical antiviral agents.
    Hamuy R; Berman B
    Eur J Dermatol; 1998; 8(5):310-9. PubMed ID: 9683881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of herpes simplex virus isolates to nucleoside analogues and the proportion of nucleoside-resistant variants after repeated topical application of penciclovir to recurrent herpes labialis.
    Shin YK; Weinberg A; Spruance S; Bernard M; Bacon TH; Boon RJ; Levin MJ
    J Infect Dis; 2003 Apr; 187(8):1241-5. PubMed ID: 12696003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management.
    Arduino PG; Porter SR
    Oral Dis; 2006 May; 12(3):254-70. PubMed ID: 16700734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection.
    Hasler-Nguyen N; Shelton D; Ponard G; Bader M; Schaffrik M; Mallefet P
    BMC Dermatol; 2009 Apr; 9():3. PubMed ID: 19341466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral agents for herpes simplex virus.
    Vere Hodge RA; Field HJ
    Adv Pharmacol; 2013; 67():1-38. PubMed ID: 23885997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of topical application of penciclovir 1% cream with acyclovir 3% cream for treatment of genital herpes: a randomized, double-blind, multicentre trial.
    Chen XS; Han GZ; Guo ZP; Lu NZ; Chen J; Wang JB;
    Int J STD AIDS; 2000 Sep; 11(9):568-73. PubMed ID: 10997497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
    Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
    J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus infection.
    Whitley RJ
    Semin Pediatr Infect Dis; 2002 Jan; 13(1):6-11. PubMed ID: 12118847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.
    Richards DM; Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Nov; 26(5):378-438. PubMed ID: 6315332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xereseâ„¢) in the treatment of recurrent herpes simplex labialis.
    Hull CM; Brunton S
    Postgrad Med; 2010 Sep; 122(5):1-6. PubMed ID: 20873400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of recurrent oral herpes simplex infections.
    Woo SB; Challacombe SJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S12.e1-18. PubMed ID: 17379150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valacyclovir for the treatment of genital herpes.
    Brantley JS; Hicks L; Sra K; Tyring SK
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):367-76. PubMed ID: 16771614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.